Dosimetric Implications of Residual Tracking Errors During Robotic SBRT of Liver Metastases

For liver tumors treated with robotic stereotactic body radiation therapy, a safety margin of 3 mm is not always sufficient to cover all residual tracking errors. Dosimetrically, this translates into only small CTV coverage reductions.